Gunawan:Research: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Template:Gunawan}} | {{Template:Gunawan}} | ||
= <font style="color:brown">Research</font> = | = <font style="color:brown">Research</font> = | ||
{|cellspacing="0" cellpadding="0" border="0" style="width: 770px; color: #000000; background-color: #FFEEDD;" | |||
|- valign="top" | |||
|width=6px rowspan="3" bgcolor="#FFEEDD"| <!----6 pixle vertical space colored----> | |||
|width=7px rowspan="3"| <!----7 pixle vertical white space ----> | |||
|height=6px| | |||
The group research activities are in the area of systems biology with particular emphasis in the development and application of systems theoretic tools for modeling, analysis, and control of diseases, including cancer and other infectious illnesses. The overarching goal is to elucidate the causality in diseases through modeling and systems analysis for the identification of drug targets, disease biomarkers, and other treatments. <BR> The specific applications include: | The group research activities are in the area of systems biology with particular emphasis in the development and application of systems theoretic tools for modeling, analysis, and control of diseases, including cancer and other infectious illnesses. The overarching goal is to elucidate the causality in diseases through modeling and systems analysis for the identification of drug targets, disease biomarkers, and other treatments. <BR> The specific applications include: | ||
Revision as of 07:05, 16 March 2008
Chemical and Biological Systems Engineering Laboratory
Research
|
The group research activities are in the area of systems biology with particular emphasis in the development and application of systems theoretic tools for modeling, analysis, and control of diseases, including cancer and other infectious illnesses. The overarching goal is to elucidate the causality in diseases through modeling and systems analysis for the identification of drug targets, disease biomarkers, and other treatments.
We are working closely with cancer biologists and infectious disease experts to validate and implement the results of our research. |
